| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/27/1993 | US5231024 Hybridoma cells |
| 07/27/1993 | US5231023 Poultry |
| 07/27/1993 | US5231022 Cellulase isolated from bacillus ferm bp-3431 or a mutant strain thereof |
| 07/27/1993 | US5231021 Cloning and expressing restriction endonucleases and modification methylases from xanthomonas |
| 07/27/1993 | US5231020 Genetic engineering of novel plant phenotypes |
| 07/27/1993 | US5231019 Transformation of hereditary material of plants |
| 07/27/1993 | US5231015 Methods of extracting nucleic acids and pcr amplification without using a proteolytic enzyme |
| 07/27/1993 | US5231012 Genes and proteins |
| 07/27/1993 | US5231010 Deletion of proline or addition of alanine-glutamine to arginine transforming S. cerevisiae vector |
| 07/27/1993 | US5231003 Monoclonal antibodies specific for toxin b of clostridium difficile |
| 07/27/1993 | US5230404 Erection scaffolding which is movable in an elevator shaft for the mounting of shaft equipment |
| 07/27/1993 | EP0651787A4 Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor. |
| 07/27/1993 | CA1320688C Affinity column and process for detection of low molecular weight toxic substances |
| 07/25/1993 | CA2059986A1 Method for rapid selection of efficient secretion vectors |
| 07/22/1993 | WO1993014406A1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 07/22/1993 | WO1993014225A1 A method for amplifying and detecting a target nucleic acid sequence of hiv-1 |
| 07/22/1993 | WO1993014223A1 Improvements in or relating to nucleic acid hybridisation assays |
| 07/22/1993 | WO1993014221A1 Detection of reverse transcriptase by dna hybridization assay |
| 07/22/1993 | WO1993014220A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
| 07/22/1993 | WO1993014219A1 Marek's disease virus recombinant poxvirus vaccine |
| 07/22/1993 | WO1993014218A1 Enzymatic rna molecules |
| 07/22/1993 | WO1993014214A1 Oxidation of glycolic acid to glyoxylic acid using a microbial cell transformant as catalyst |
| 07/22/1993 | WO1993014213A1 Novel plant gene regulatory element |
| 07/22/1993 | WO1993014212A1 Transgenic plants with increased solids content |
| 07/22/1993 | WO1993014211A1 Regulation of plant genes |
| 07/22/1993 | WO1993014210A1 Virus resistant corn plants |
| 07/22/1993 | WO1993014209A1 Vaccines based on streptokinase |
| 07/22/1993 | WO1993014208A2 Hepatitis e virus vaccine and method |
| 07/22/1993 | WO1993014207A1 Chimeric immunogens |
| 07/22/1993 | WO1993014206A2 Synthetic peptides for a rubella vaccine |
| 07/22/1993 | WO1993014205A1 Crystal proteins of bacillus thuringiensis, genes encoding them, and hosts expressing them |
| 07/22/1993 | WO1993014204A1 Babesial antigens |
| 07/22/1993 | WO1993014203A1 Lymphotoxins, expression vector therefor, and production of lymphotoxins with said vector |
| 07/22/1993 | WO1993014202A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 07/22/1993 | WO1993014201A1 Dna encoding a human 5-ht1f receptor and uses thereof |
| 07/22/1993 | WO1993014200A1 Transgenic animal models for alzheimer's disease |
| 07/22/1993 | WO1993014195A1 Vaccine containing acemannan as an adjuvant |
| 07/22/1993 | WO1993014194A1 Recombinant swinepox virus |
| 07/22/1993 | WO1993014188A1 Targeted virus |
| 07/22/1993 | WO1993014124A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 07/22/1993 | WO1993014123A1 A novel human kunitz-type protease inhibitor and variants thereof |
| 07/22/1993 | WO1993014122A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | WO1993014121A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | WO1993014120A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | WO1993014119A1 Human kunitz-type protease inhibitor variants |
| 07/22/1993 | WO1993014117A1 Peptides of the casein macropeptide, antibodies directed against said peptides, and applications |
| 07/22/1993 | WO1993014116A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | WO1993013807A1 A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy |
| 07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
| 07/22/1993 | WO1993013798A1 Treatment for asthma |
| 07/22/1993 | WO1993013784A1 Platelet transfusion |
| 07/22/1993 | WO1993013740A2 Antiparasitic oligonucleotides active against drug resistant malaria |
| 07/22/1993 | WO1993010239A3 Hepatitis-c virus testing |
| 07/22/1993 | WO1993009235A3 Ubiquitin-specific proteases |
| 07/22/1993 | CA2128235A1 Detection of reverse transcriptase by dna hybridization assay |
| 07/22/1993 | CA2127883A1 A method for amplifying and detecting a target nucleic acid sequence of hiv-1 |
| 07/22/1993 | CA2127710A1 Crystal proteins of bacillus thuringiensis, genes encoding them, and hosts expressing them |
| 07/22/1993 | CA2127540A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 07/22/1993 | CA2127532A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
| 07/22/1993 | CA2127473A1 Peptides of the casein macropeptide, antibodies directed against said peptides and applications |
| 07/22/1993 | CA2127461A1 Enzymatic rna molecules |
| 07/22/1993 | CA2127368A1 Platelet transfusion |
| 07/22/1993 | CA2127250A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | CA2127249A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | CA2127248A1 Human kunitz-type protease inhibitor variants |
| 07/22/1993 | CA2127247A1 A novel human kunitz-type protease inhibitor and variants thereof |
| 07/22/1993 | CA2127246A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | CA2126979A1 Antiparasitic oligonucleotides active against drug resistant malaria |
| 07/22/1993 | CA2125701A1 Hepatitis e virus vaccine and method |
| 07/22/1993 | CA2125700A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | CA2105284A1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 07/21/1993 | EP0552031A1 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 07/21/1993 | EP0551842A2 Enzyme donor and enzyme-acceptor polypeptides and recombinant DNA vector comprising a DNA coding for said polypeptides |
| 07/21/1993 | EP0551750A2 Recombinant DNA compounds and expression vectors encoding para-nitrobenzyl esterase activity from bacillus |
| 07/21/1993 | EP0551671A1 Treponema hyodysenteriae vaccine |
| 07/21/1993 | EP0551535A1 Process for the purification of recombinant human beta interferon, beta interferon thus purified, and pharmaceutical compositions which contain them |
| 07/21/1993 | EP0551506A1 System for protein expression and secretion especially in corynebacteria |
| 07/21/1993 | EP0551501A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 07/21/1993 | EP0551449A1 Method for producing a subunit vaccine against porcine parvovirus |
| 07/21/1993 | EP0551446A1 A onco-fetal gene, gene product and uses therefor |
| 07/21/1993 | EP0551440A1 Design of bioactive peptides based on immunoglobulin structure |
| 07/21/1993 | EP0551438A1 Surface expression libraries of randomized peptides |
| 07/21/1993 | EP0551400A1 Method for treating inflammation using anti-idiotypic antibodies |
| 07/21/1993 | EP0551394A1 Trichoderma reesei containing deleted and/or enriched cellulase and other enzyme genes and cellulase compositions derived therefrom |
| 07/21/1993 | EP0551386A1 Methods for treating cotton-containing fabrics with cellulase |
| 07/21/1993 | EP0551329A1 Aprotinin analogues |
| 07/21/1993 | EP0551325A1 Method of testing for salmonella |
| 07/21/1993 | EP0551324A1 Salmonella polynucleotide sequence. |
| 07/21/1993 | EP0551319A1 Y-chromosome specific polynucleotide probes for prenatal sexing |
| 07/21/1993 | EP0551305A1 Method for enzymatic regeneration of cell culture media and kits therefor |
| 07/21/1993 | EP0551301A1 Cd53 cell surface antigen and use thereof |
| 07/21/1993 | EP0551294A1 Ribozyme inhibition of bcr-abl gene expression |
| 07/21/1993 | EP0543924A4 Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
| 07/21/1993 | EP0536215A4 Neurofibromatosis gene |
| 07/21/1993 | EP0462187B1 Pharmaceutical composition useful in the prevention or treatment of papillomavirus-induced tumours |
| 07/21/1993 | EP0456667B1 Method for detecting the presence of mercury using microorganisms with mercury-enhanced bioluminescence |
| 07/21/1993 | EP0342188B1 Method for the removal of undesired cells from human lymphocyte populations, application of the method in monoclonal antibody production and kit therefor |
| 07/21/1993 | EP0245481B1 Yeast strains |
| 07/21/1993 | EP0242359B1 A cloning vehicle for cloning a large fragment of dna and a vaccine comprising 987p fimbrial protein |
| 07/21/1993 | EP0179887B1 Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc. |